Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368

Localized Surface Plasmon Resonance Spectroscopy and Sensing

Willets, K. A., & Van Duyne, R. P. (2007) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.58.032806.104607 · Cited by 6,171

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379

Cell-free nucleic acids as biomarkers in cancer patients

Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891

Liquid biopsies come of age: Towards implementation of circulating tumour DNA

Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

Hindson, B. J., Ness, K. D., Masquelier, D. A., Belgrader, P., Heredia, N. J., Makarewicz, A. J., Bright, I. J., Lucero, M. Y., Hiddessen, A. L., Legler, T. C., et al. (2011) · Analytical Chemistry · doi:10.1021/ac202028g · Cited by 2,792

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207

Integrating liquid biopsies into the management of cancer

Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908

Untitled work

(1977) · PubMed · Cited by 1,801

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624

Double-stranded DNA in exosomes: a novel biomarker in cancer detection

Thakur, B. K., Zhang, H., Becker, A., Matei, I., Huang, Y., Costa-Silva, B., Zheng, Y., Hoshino, A., Brazier, H., Xiang, J., et al. (2014) · Cell Research · doi:10.1038/cr.2014.44 · Cited by 1,596

Performance comparison of benchtop high-throughput sequencing platforms

Loman, N. J., Misra, R. V., Dallman, T. J., Constantinidou, C., Gharbia, S. E., Wain, J., & Pallen, M. J. (2012) · Nature Biotechnology · doi:10.1038/nbt.2198 · Cited by 1,337

Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297

Detection and quantification of mutations in the plasma of patients with colorectal tumors

Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188

Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna

(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169

Rapid Clearance of Fetal DNA from Maternal Plasma

Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150

Detection and quantification of rare mutations with massively parallel sequencing

Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,082

Plasmonics for future biosensors

Brolo, A. G. (2012) · Nature Photonics · doi:10.1038/nphoton.2012.266 · Cited by 1,074

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921

Circulating nucleic acids (CNAs) and cancer—A survey

Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer

Oxnard, G. R., Thress, K. S., Alden, R. S., Lawrance, R., Paweletz, C. P., Cantarini, M., Yang, J. C.-H., Barrett, J. C., & Jänne, P. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.7162 · Cited by 850

Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations

Dressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

Church, T. R., Wandell, M., Lofton-Day, C., Mongin, S. J., Burger, M., Payne, S. R., Castaños-Vélez, E., Blumenstein, B. A., Rösch, T., Osborn, N., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304149 · Cited by 796

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.

(15031584), Y. M. D. L., Chan, L. Y. S., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T. �., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 777

Circulating Tumor DNA as a Liquid Biopsy for Cancer

Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767

Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients

Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Beljanski, M. (2009) · Oncology · doi:10.1159/000226740 · Cited by 733

Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA

Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695

Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA

Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 694

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

Thierry, A. R., Mouliere, F., El Messaoudi, S., Mollevi, C., Lopez-Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 678

Fragment Length of Circulating Tumor DNA

Underhill, H. R., Kitzman, J. O., Hellwig, S., Welker, N. C., Daza, R., Baker, D. N., Gligorich, K. M., Rostomily, R. C., Bronner, M. P., & Shendure, J. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006162 · Cited by 671

Microsatellite alterations in serum DNA of head and neck cancer patients

Nawroz, H., Koch, W., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 658

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Chabon, J. J., Simmons, A. D., Lovejoy, A. F., Esfahani, M. S., Newman, A. M., Haringsma, H. J., Kurtz, D. M., Stehr, H., Scherer, F., Karlovich, C. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11815 · Cited by 648

Microsatellite alterations in plasma DNA of small cell lung cancer patients

Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647

Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

Leary, R. J., Sausen, M., Kinde, I., Papadopoulos, N., Carpten, J. D., Craig, D., O’Shaughnessy, J., Kinzler, K. W., Parmigiani, G., Vogelstein, B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004742 · Cited by 635

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer

Schiavon, G., Hrebien, S., Garcia-Murillas, I., Cutts, R. J., Pearson, A., Tarazona, N., Fenwick, K., Kozarewa, I., Lopez-Knowles, E., Ribas, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7551 · Cited by 575

High Fragmentation Characterizes Tumour-Derived Circulating DNA

Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023418 · Cited by 567

Circulating cell free DNA: Preanalytical considerations

El Messaoudi, S., Rolet, F., Mouliere, F., & Thierry, A. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.022 · Cited by 560

Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer

Sozzi, G., Conte, D., Leon, M., Cirincione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.006 · Cited by 552

Quantitative and sensitive detection of rare mutations using droplet-based microfluidics

Pekin, D., Skhiri, Y., Baret, J.-C., Le Corre, D., Mazutis, L., Ben Salem, C., Millot, F., El Harrak, A., Hutchison, J. B., Larson, J. W., et al. (2011) · Lab on a Chip · doi:10.1039/c1lc20128j · Cited by 540

Attomolar DNA detection with chiral nanorod assemblies

Ma, W., Kuang, H., Xu, L., Ding, L., Xu, C., Wang, L., & Kotov, N. A. (2013) · Nature Communications · doi:10.1038/ncomms3689 · Cited by 531

Soluble normal and mutated DNA sequences from single-copy genes in human blood.

Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., & Yao, S. (1994) · PubMed · Cited by 530

Digital PCR hits its stride

Baker, M. (2012) · Nature Methods · doi:10.1038/nmeth.2027 · Cited by 524

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer

deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K. V., Grützmann, R., Pilarsky, C., Habermann, J. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115808 · Cited by 522

Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.

Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517

Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

Leary, R. J., Kinde, I., Diehl, F., Schmidt, K., Clouser, C., Duncan, C., Antipova, A., Lee, C., McKernan, K., De La Vega, F. M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000702 · Cited by 517

Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing

Chan, K. A., Jiang, P., Zheng, Y. W., Liao, G. J., Sun, H., Wong, J., Siu, S. S. N., Chan, W. C., Chan, S. L., Chan, A. T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196014 · Cited by 488

Circulating Tumor Cells and Circulating Tumor DNA

Alix-Panabières, C., Schwarzenbach, H., & Pantel, K. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062310-094219 · Cited by 485

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA

Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., Lovejoy, A. F., Chabon, J. J., Klass, D. M., Liu, C. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8545 · Cited by 484

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer

Murtaza, M., Dawson, S.-J., Pogrebniak, K., Rueda, O. M., Provenzano, E., Grant, J., Chin, S.-F., Tsui, D. W. Y., Marass, F., Gale, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9760 · Cited by 483

Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

Wang, Y., Springer, S., Zhang, M., McMahon, K. W., Kinde, I., Dobbyn, L., Ptak, J., Brem, H., Chaichana, K., Gallia, G. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511694112 · Cited by 454

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Olsson, E., Winter, C., George, A., Chen, Y., Howlin, J., Tang, M. E., Dahlgren, M., Schulz, R., Grabau, D., van Westen, D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404913 · Cited by 453

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., Cole, R., McWalter, G., Walker, J., Dearden, S., Webster, A., Milenkova, T., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000263 · Cited by 448

Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

Chan, K. C. A., Jiang, P., Chan, C. W. M., Sun, K., Wong, J., Hui, E. P., Chan, S. L., Chan, W. C., Hui, D. S. C., Ng, S. S. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313995110 · Cited by 447

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., McCormack, R., Webster, A., & Milenkova, T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.721 · Cited by 412

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Beaver, J. A., Jelovac, D., Balukrishna, S., Cochran, R. L., Croessmann, S., Zabransky, D. J., Wong, H. Y., Valda Toro, P., Cidado, J., Blair, B. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2933 · Cited by 398

Cell-Free DNA in Human Blood Plasma: Length Measurements in Patients with Pancreatic Cancer and Healthy Controls

Giacona, M. B., Ruben, G. C., Iczkowski, K. A., Roos, T. B., Porter, D. M., & Sorenson, G. D. (1998) · Pancreas · doi:10.1097/00006676-199807000-00012 · Cited by 387

Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non–Small Cell Lung Cancer Patients

Yung, T. K. F., Chan, K. C. A., Mok, T. S. K., Tong, J., To, K.-F., & Lo, Y. M. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2622 · Cited by 385

Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.

Sozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 380

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

Kawakami, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1805 · Cited by 376

Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection

Aravanis, A. M., Lee, M., & Klausner, R. D. (2017) · Cell · doi:10.1016/j.cell.2017.01.030 · Cited by 367

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

Heitzer, E., Ulz, P., Belic, J., Gutschi, S., Quehenberger, F., Fischereder, K., Benezeder, T., Auer, M., Pischler, C., Mannweiler, S., et al. (2013) · Genome Medicine · doi:10.1186/gm434 · Cited by 357

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

Ignatiadis, M., Lee, M., & Jeffrey, S. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1190 · Cited by 355

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

Volik, S., Alcaide, M., Morin, R. D., & Collins, C. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0044 · Cited by 349

Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature

Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337

Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU Repeats

Umetani, N., Kim, J., Hiramatsu, S., Reber, H. A., Hines, O. J., Bilchik, A. J., & Hoon, D. S. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068577 · Cited by 331

Increased plasma DNA integrity in cancer patients.

Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326

The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics

Jiang, P., & Lo, Y. M. D. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.009 · Cited by 312

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma

Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Higgins, M. J., Jelovac, D., Barnathan, E., Blair, B., Slater, S., Powers, P., Zorzi, J., Jeter, S. C., Oliver, G. R., Fetting, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2696 · Cited by 309

Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299

Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification

Devonshire, A. S., Whale, A. S., Gutteridge, A., Jones, G., Cowen, S., Foy, C. A., & Huggett, J. F. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7835-3 · Cited by 299

Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study

Parkinson, C. A., Gale, D., Piskorz, A. M., Biggs, H., Hodgkin, C., Addley, H., Freeman, S., Moyle, P., Sala, E., Sayal, K., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002198 · Cited by 297

Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis

Lecomte, T., Berger, A., Zinzindohoué, F., Micard, S., Landi, B., Blons, H., Beaune, P., Cugnenc, P., & Laurent‐Puig, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10526 · Cited by 292

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Gautschi, O., Bigosch, C., Huegli, B., Jermann, M., Marx, A., Chassé, E., Ratschiller, D., Weder, W., Joerger, M., Betticher, D. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.123 · Cited by 275

An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum

Das, J., Ivanov, I., Montermini, L., Rak, J., Sargent, E. H., & Kelley, S. O. (2015) · Nature Chemistry · doi:10.1038/nchem.2270 · Cited by 274

Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

Lebofsky, R., Decraene, C., Bernard, V., Kamal, M., Blin, A., Leroy, Q., Rio Frio, T., Pierron, G., Callens, C., Bieche, I., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.003 · Cited by 269

BEAMing up for detection and quantification of rare sequence variants

Li, M., Diehl, F., Dressman, D., Vogelstein, B., & Kinzler, K. W. (2006) · Nature Methods · doi:10.1038/nmeth850 · Cited by 261

Quantitative Cell-Free DNA, KRAS , and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan

Spindler, K.-L. G., Pallisgaard, N., Vogelius, I., & Jakobsen, A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0564 · Cited by 251

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

Paweletz, C. P., Sacher, A. G., Raymond, C. K., Alden, R. S., O'Connell, A., Mach, S. L., Kuang, Y., Gandhi, L., Kirschmeier, P., English, J. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1627-t · Cited by 244

High-Resolution Profiling of Fetal DNA Clearance from Maternal Plasma by Massively Parallel Sequencing

Yu, S. C., Lee, S. W., Jiang, P., Leung, T. Y., Chan, K. A., Chiu, R. W., & Lo, Y. D. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.203679 · Cited by 242

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer

Rothé, F., Laes, J.-F., Lambrechts, D., Smeets, D., Vincent, D., Maetens, M., Fumagalli, D., Michiels, S., Drisis, S., Moerman, C., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu288 · Cited by 233

Changes in Concentration of DNA in Serum and Plasma during Storage of Blood Samples

Jung, M., Klotzek, S., Lewandowski, M., Fleischhacker, M., & Jung, K. (2003) · Clinical Chemistry · doi:10.1373/49.6.1028 · Cited by 233

Circulating DNA and DNase Activity in Human Blood

TAMKOVICH, S. N., CHEREPANOVA, A. V., KOLESNIKOVA, E. V., RYKOVA, E. Y., PYSHNYI, D. V., VLASSOV, V. V., & LAKTIONOV, P. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.026 · Cited by 232

Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer

Mouliere, F., El Messaoudi, S., Pang, D., Dritschilo, A., & Thierry, A. R. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.005 · Cited by 230

Circulating DNA: a new diagnostic gold mine?

Ziegler, A., Zangemeister-Wittke, U., & Stahel, R. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00077-4 · Cited by 228

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types

Shu, Y., Wu, X., Tong, X., Wang, X., Chang, Z., Mao, Y., Chen, X., Sun, J., Wang, Z., Hong, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00520-1 · Cited by 223

Digital karyotyping

Wang, T.-L., Maierhofer, C., Speicher, M. R., Lengauer, C., Vogelstein, B., Kinzler, K. W., & Velculescu, V. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202610899 · Cited by 219

The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis

Song, L., Jia, J., Peng, X., Xiao, W., & Li, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03321-8 · Cited by 207

DNA Clutch Probes for Circulating Tumor DNA Analysis

Das, J., Ivanov, I., Sargent, E. H., & Kelley, S. O. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b05679 · Cited by 206

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

Board, R. E., Wardley, A. M., Dixon, J. M., Armstrong, A. C., Howell, S., Renshaw, L., Donald, E., Greystoke, A., Ranson, M., Hughes, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0747-9 · Cited by 201

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.

Mutirangura, A., Pornthanakasem, W., Theamboonlers, A., Sriuranpong, V., Lertsanguansinchi, P., Yenrudi, S., Voravud, N., Supiyaphun, P., & Poovorawan, Y. (1998) · PubMed · Cited by 197

EDTA Is a Better Anticoagulant than Heparin or Citrate for Delayed Blood Processing for Plasma DNA Analysis

Lam, N. Y. L., Rainer, T. H., Chiu, R. W. K., & Lo, Y. M. D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026013 · Cited by 196

Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors

McBride, D. J., Orpana, A. K., Sotiriou, C., Joensuu, H., Stephens, P. J., Mudie, L. J., Hämäläinen, E., Stebbings, L. A., Andersson, L. C., Flanagan, A. M., et al. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20815 · Cited by 196

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer

Takai, E., Totoki, Y., Nakamura, H., Morizane, C., Nara, S., Hama, N., Suzuki, M., Furukawa, E., Kato, M., Hayashi, H., et al. (2015) · Scientific Reports · doi:10.1038/srep18425 · Cited by 192

Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.

Capone, R. B., Pai, S. I., Koch, W. M., Gillison, M. L., Nawroz-Danish, H., Westra, W. H., Daniel, R. W., Shah, K. V., & Sidransky, D. (2000) · PubMed · Cited by 188

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

Frenel, J. S., Carreira, S., Goodall, J., Roda, D., Perez-Lopez, R., Tunariu, N., Riisnaes, R., Miranda, S., Figueiredo, I., Nava-Rodrigues, D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0584 · Cited by 185

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

Wang, T.-L., Diaz, L. A., Romans, K., Bardelli, A., Saha, S., Galizia, G., Choti, M., Donehower, R., Parmigiani, G., Shih, I.-M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308716101 · Cited by 183

Genomic analysis of circulating cell-free DNA infers breast cancer dormancy

Shaw, J. A., Page, K., Blighe, K., Hava, N., Guttery, D., Ward, B., Brown, J., Ruangpratheep, C., Stebbing, J., Payne, R., et al. (2012) · Genome Research · doi:10.1101/gr.123497.111 · Cited by 180

Methylated circulating tumor DNA in blood: power in cancer prognosis and response

Warton, K., Mahon, K. L., & Samimi, G. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0369 · Cited by 176

Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer

Heitzer, E., Auer, M., Hoffmann, E. M., Pichler, M., Gasch, C., Ulz, P., Lax, S., Waldispuehl‐Geigl, J., Mauermann, O., Mohan, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28030 · Cited by 175

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

De Mattos-Arruda, L., Cortes, J., Santarpia, L., Vivancos, A., Tabernero, J., Reis-Filho, J. S., & Seoane, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.80 · Cited by 174

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations

Chang-Hao Tsao, S., Weiss, J., Hudson, C., Christophi, C., Cebon, J., Behren, A., & Dobrovic, A. (2015) · Scientific Reports · doi:10.1038/srep11198 · Cited by 173

Comparison of four digital PCR platforms for accurate quantification of DNA copy number of a certified plasmid DNA reference material

Dong, L., Meng, Y., Sui, Z., Wang, J., Wu, L., & Fu, B. (2015) · Scientific Reports · doi:10.1038/srep13174 · Cited by 170

Plasma cell‐free DNA in ovarian cancer: An independent prognostic biomarker

Kamat, A. A., Baldwin, M., Urbauer, D., Dang, D., Han, L. Y., Godwin, A., Karlan, B. Y., Simpson, J. L., Gershenson, D. M., Coleman, R. L., et al. (2010) · Cancer · doi:10.1002/cncr.24997 · Cited by 169

A label-free ultrasensitive electrochemical DNA sensor based on thin-layer MoS2 nanosheets with high electrochemical activity

Wang, X., Nan, F., Zhao, J., Yang, T., Ge, T., & Jiao, K. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.09.030 · Cited by 167

Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor–Positive Metastatic Breast Cancer

Guttery, D. S., Page, K., Hills, A., Woodley, L., Marchese, S. D., Rghebi, B., Hastings, R. K., Luo, J., Pringle, J. H., Stebbing, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238717 · Cited by 164

TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study

Gormally, E., Vineis, P., Matullo, G., Veglia, F., Caboux, E., Le Roux, E., Peluso, M., Garte, S., Guarrera, S., Munnia, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4556 · Cited by 164

Early detection of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA analysis in a surveillance program

Chan, K. C. A., Hung, E. C. W., Woo, J. K. S., Chan, P. K. S., Leung, S., Lai, F. P. T., Cheng, A. S. M., Yeung, S. W., Chan, Y. W., Tsui, T. K. C., et al. (2013) · Cancer · doi:10.1002/cncr.28001 · Cited by 163

Effects of Prolonged Storage of Whole Plasma or Isolated Plasma DNA on the Results of Circulating DNA Quantification Assays

Sozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Verderio, P., & Pastorino, U. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji432 · Cited by 163

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

Madhavan, D., Wallwiener, M., Bents, K., Zucknick, M., Nees, J., Schott, S., Cuk, K., Riethdorf, S., Trumpp, A., Pantel, K., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2946-2 · Cited by 161

Localized surface plasmon resonance: a unique property of plasmonic nanoparticles for nucleic acid detection

Fong, K. E., & Yung, L.-Y. L. (2013) · Nanoscale · doi:10.1039/c3nr02257a · Cited by 159

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Ignatiadis, M., & Dawson, S.-J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu480 · Cited by 158

Optimizing the yield and utility of circulating cell-free DNA from plasma and serum

Xue, X., Teare, M. D., Holen, I., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.02.018 · Cited by 156

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

Madic, J., Kiialainen, A., Bidard, F., Birzele, F., Ramey, G., Leroy, Q., Frio, T. R., Vaucher, I., Raynal, V., Bernard, V., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29265 · Cited by 153

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Banks, K. C., Lanman, R. B., Talasaz, A. H., Parker, B. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7110 · Cited by 152

Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation

Skvortsova, T. E., RYKOVA, E. Y., TAMKOVICH, S. N., Bryzgunova, O. E., Starikov, A. V., Kuznetsova, N. P., Vlassov, V. V., & Laktionov, P. P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603117 · Cited by 150

Effect of Highly Fragmented DNA on PCR

Golenberg, E. M., Bickel, A., & Weihs, P. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.24.5026 · Cited by 147

Nucleosomes in Serum as a Marker for Cell Death

Holdenrieder, S., Stieber, P., Bodenmüller, H., Fertig, G., Fürst, H., Schmeller, N. T., Untch, M., & Seidel, D. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.095 · Cited by 147

Impacts of degraded DNA on restriction enzyme associated DNA sequencing ( RADS eq)

Graham, C. F., Glenn, T. C., McArthur, A. G., Boreham, D. R., Kieran, T. J., Lance, S. L., Manzon, R. G., Martino, J. A., Pierson, T. W., Rogers, S. M., et al. (2015) · Molecular Ecology Resources · doi:10.1111/1755-0998.12404 · Cited by 145

The dynamic range of circulating tumor DNA in metastatic breast cancer

Heidary, M., Auer, M., Ulz, P., Heitzer, E., Petru, E., Gasch, C., Riethdorf, S., Mauermann, O., Lafer, I., Pristauz, G., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0421-y · Cited by 145

Nanoplasmonic biosensor: Detection and amplification of dual bio-signatures of circulating tumor DNA

Anh, N. T. V., & Sim, S. J. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.09.003 · Cited by 143

Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Dawson, S.-J., Rosenfeld, N., & Caldas, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306040 · Cited by 140

Cell-free circulating tumor DNA in cancer

Qin, Z., Ljubimov, V. A., Zhou, C., Tong, Y., & Liang, J. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0092-4 · Cited by 139

A Quantitative Fluorescence-Based Microplate Assay for the Determination of Double-Stranded DNA Using SYBR Green I and a Standard Ultraviolet Transilluminator Gel Imaging System

Vitzthum, F., Geiger, G., Bisswanger, H., et al. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4298 · Cited by 136

Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing

Ståhlberg, A., Krzyzanowski, P. M., Egyud, M., Filges, S., Stein, L. D., & Godfrey, T. E. (2017) · Nature Protocols · doi:10.1038/nprot.2017.006 · Cited by 134

Assessment of Plasma DNA Levels, Allelic Imbalance, and CA 125 as Diagnostic Tests for Cancer

Chang, H. W. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.22.1697 · Cited by 132

Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients

Silva, J. M., Domínguez, G., Villanueva, M. J., Gonzalez, R., Garcia, J. M., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690495 · Cited by 131

Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma

Breitbach, S. A., Tug, S., Helmig, S., Zahn, D., Kubiak, T., Michal, M., Gori, T., Ehlert, T., Beiter, T., & Simon, P. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087838 · Cited by 131

Circulating tumor cells and DNA as liquid biopsies

Heitzer, E., Auer, M., Ulz, P., Geigl, J. B., & Speicher, M. R. (2013) · Genome Medicine · doi:10.1186/gm477 · Cited by 130

Cell-free DNA as a diagnostic marker for cancer: current insights

Salvi, S., Gurioli, G., Giorgi, U. D., Conteduca, V., Tedaldi, G., Calistri, D., & Casadio, V. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s100901 · Cited by 130

An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum

Jen, J., Wu, L. J., & Sidransky, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06581.x · Cited by 128

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer

Mattos‐Arruda, L. D., & Caldas, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.001 · Cited by 127

Circulating tumour‐associated plasma DNA represents an independent and informative predictor of prostate cancer

Chun, F. K. ‐., Müller, I., Lange, I., et al. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06352.x · Cited by 120

Detection of Circulating Tumor DNA in Human Blood via DNA-Mediated Surface-Enhanced Raman Spectroscopy of Single-Walled Carbon Nanotubes

Zhou, Q., Zheng, J., Qing, Z., Zheng, M., Yang, J., Yang, S., Ying, L., & Yang, R. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00108 · Cited by 119

Simple, Sensitive and Accurate Multiplex Detection of Clinically Important Melanoma DNA Mutations in Circulating Tumour DNA with SERS Nanotags

Wee, E. J. H., Wang, Y., Tsao, S. C., & Trau, M. (2016) · Theranostics · doi:10.7150/thno.15871 · Cited by 119

RNA Biomarkers: Diagnostic and Prognostic Potentials and Recent Developments of Electrochemical Biosensors

Islam, M. N., Masud, M. K., Haque, M. H., Hossain, M. S. A., Yamauchi, Y., Nguyen, N., & Shiddiky, M. J. A. (2017) · Small Methods · doi:10.1002/smtd.201700131 · Cited by 118

Cell‐free DNA and RNA in Plasma as a New Molecular Marker for Prostate and Breast Cancer

Papadopoulou, E., Davilas, E., Sotiriou, V., Georgakopoulos, E., Georgakopoulou, S., Koliopanos, A., Aggelakis, F., Dardoufas, K., Agnanti, N., Karydas, I., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.032 · Cited by 117

Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients

Sunami, E., Shinozaki, M., Higano, C. S., Wollman, R. C., Dorff, T. B., Tucker, S. J., Martinez, S. R., Singer, F. R., & Hoon, D. S. �. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.108498 · Cited by 117

Circulating Tumor DNA Outperforms Circulating Tumor Cells for KRAS Mutation Detection in Thoracic Malignancies

Freidin, M. B., Freydin, M., Leung, M., Montero, Á., Nicholson, A. G., & Lim, E. K. S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242453 · Cited by 113

Human papillomavirus DNA in plasma of patients with cervical cancer

Pornthanakasem, W., Shotelersuk, K., Termrungruanglert, W., Voravud, N., Niruthisard, S., & Mutirangura, A. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-2 · Cited by 112

Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma

Mauger, F., Dulary, C., Daviaud, C., Deleuze, J., & Tost, J. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8846-4 · Cited by 108

Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

Xi, L., Pham, T. H.-T., Payabyab, E. C., Sherry, R. M., Rosenberg, S. A., & Raffeld, M. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0613 · Cited by 105

Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients

Beau‐Faller, M., Gaub, M. P., Schneider, A., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11079 · Cited by 101

A new methodology to preserve the original proportion and integrity of cell‐free fetal DNA in maternal plasma during sample processing and storage

Fernando, M. R., Chen, K., Norton, S., Krzyzanowski, G. D., Bourne, D., Hunsley, B. A., Ryan, W. L., & Bassett, C. H. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2484 · Cited by 101

Quantifying EGFR Alterations in the Lung Cancer Genome with Nanofluidic Digital PCR Arrays

Wang, J., Ramakrishnan, R., Tang, Z., Fan, W., Kluge, A., Dowlati, A., Jones, R. C., & Ma, P. C. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.134973 · Cited by 100

Role of Cell‐Free Plasma DNA as a Diagnostic Marker for Prostate Cancer

Allen, D. J., Butt, A., Cahill, D. J., Wheeler, M., Popert, R., & Swaminathan, R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.013 · Cited by 99

Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer

Jung, K., Stephan, C., Lewandowski, M., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.11.023 · Cited by 98

Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management

Vendrell, J. A., Mau‐Them, F. T., Béganton, B., Godreuil, S., Coopman, P. J., & Solassol, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020264 · Cited by 98

DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal Cancer

Boynton, K. A., Summerhayes, I. C., Ahlquist, D. A., & Shuber, A. P. (2003) · Clinical Chemistry · doi:10.1373/49.7.1058 · Cited by 94

Circulating-tumor DNA as an early detection and diagnostic tool

Butler, T. M., Spellman, P. T., & Gray, J. W. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.12.003 · Cited by 93

Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients

Taback, B., O'Day, S. J., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.004 · Cited by 91

Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma

Madic, J., Piperno-Neumann, S., Servois, V., Rampanou, A., Milder, M., Trouiller, B., Gentien, D., Saada, S., Assayag, F., Thuleau, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0309 · Cited by 91

Changes in mutational status during third‐line treatment for metastatic colorectal cancer—Results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma

Spindler, K. G., Pallisgaard, N., Andersen, R. F., & Jakobsen, A. K. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28863 · Cited by 91

Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer

Tham, C., Chew, M., Soong, R., Lim, J.-F., Ang, M., Tang, C., Zhao, Y., Ong, S. Y. K., & Liu, Y. (2014) · Cancer · doi:10.1002/cncr.28802 · Cited by 90

Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients.

Combaret, V., Audoynaud, C., Iacono, I., Favrot, M., Schell, M., Bergeron, C., & Puisieux, A. (2002) · PubMed · Cited by 86

The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma

Ren, N., Qin, L., Tu, H., et al. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0049-5 · Cited by 83

Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

Taback, B., Fujiwara, Y., Wang, H., et al. (2001) · PubMed · Cited by 83

Reversible acetylation on Lys501 regulates the activity of RNase II

Song, L., Wang, G., Malhotra, A., Deutscher, M. P., & Liang, W. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw053 · Cited by 82

SEPT9

Song, L., & Li, Y. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.07.004 · Cited by 82

Ultrasensitive Detection of Multiplexed Somatic Mutations Using MALDI-TOF Mass Spectrometry

Mosko, M., Nakorchevsky, A., Flores, E., Metzler, H., Ehrich, M., van den Boom, D., Sherwood, J. L., & Nygren, A. O. H. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.08.001 · Cited by 81

Quantification of circulating cell‐free DNA in the plasma of cancer patients during radiation therapy

Cheng, C., Omura‐Minamisawa, M., Kang, Y. H., Hara, T., Koike, I., & Inoue, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01021.x · Cited by 80

A new method for non-labeling attomolar detection of diseases based on an individual gold nanorod immunosensor

Truong, P. L., Cao, C., Park, S., Kim, M., & Sim, S. J. (2011) · Lab on a Chip · doi:10.1039/c1lc20085b · Cited by 80

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer

Ruth E Board, Knight, L., Greystoke, A., Blackhall, F. H., Hughes, A. M., Dive, C., & Ranson, M. (2007) · Biomarker Insights · doi:10.1177/117727190700200003 · Cited by 79

Single copy-sensitive electrochemical assay for circulating methylated DNA in clinical samples with ultrahigh specificity based on a sequential discrimination–amplification strategy

Wang, X., Chen, F., Zhang, D., Zhao, Y., Wei, J., Wang, L., Song, S., Fan, C., & Zhao, Y. (2017) · Chemical Science · doi:10.1039/c7sc01035d · Cited by 73

DNA methylation in circulating tumour DNA as a biomarker for cancer.

Ruth E Board, Knight, L., Greystoke, A., Blackhall, F. H., Hughes, A. M., Dive, C., & Ranson, M. (2008) · PubMed Central · Cited by 72

Influence of Temperature during Transportation on Cell-Free DNA Analysis

Hidestrand, M., Stokowski, R. P., Song, K., Oliphant, A., Deavers, J., Goetsch, M. A., Simpson, P. M., Kuhlmann, R. S., Ames, M. B., Mitchell, M., et al. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000335020 · Cited by 72

Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review

Fan, G., Zhang, K., Yang, X., Ding, J., Wang, Z., & Li, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171991 · Cited by 72

Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients

Liggett, T., Melnikov, A. A., Marks, J. R., & Levenson, V. (2010) · International Journal of Cancer · doi:10.1002/ijc.25363 · Cited by 68

Nitrogen-doped multiple graphene aerogel/gold nanostar as the electrochemical sensing platform for ultrasensitive detection of circulating free DNA in human serum

Ruiyi, L., Ling, L., Hongxia, B., & Li, Z. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.12.092 · Cited by 68

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study

Sueoka‐Aragane, N., Katakami, N., Satouchi, M., Yokota, S., Aoe, K., Iwanaga, K., Otsuka, K., Morita, S., Kimura, S. H., Negoro, S., et al. (2015) · Cancer Science · doi:10.1111/cas.12847 · Cited by 68

Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer

Ling, Z., Lv, P., Lu, X., Yu, J.-L., Han, J., Ying, L., Zhu, X., Zhu, W., Fang, X., Wang, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067195 · Cited by 67

Use of Real-Time Quantitative PCR to Compare DNA Isolation Methods

de Kok, J. B., Hendriks, J. C. M., van Solinge, W. W., et al. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.10.2201 · Cited by 66

Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

Harris, F. R., Kovtun, I. V., Smadbeck, J. B., Multinu, F., Jatoi, A., Kosari, F., Kalli, K. R., Murphy, S. J., Halling, G. C., Johnson, S. H., et al. (2016) · Scientific Reports · doi:10.1038/srep29831 · Cited by 66

Dielectrophoretic isolation and detection of cancer‐related circulating cell‐free DNA biomarkers from blood and plasma

Sonnenberg, A., Marciniak, J. Y., Skowronski, E. A., Manouchehri, S., Rassenti, L. Z., Ghia, E. M., Widhopf, G. F., Kipps, T. J., & Heller, M. J. (2014) · Electrophoresis · doi:10.1002/elps.201400016 · Cited by 63

Improved Method for Isolating Cell-Free DNA

Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.051003 · Cited by 63

Decoding Circulating Nucleic Acids in Human Serum Using Microfluidic Single Molecule Spectroscopy

Liu, K. J., Brock, M. V., Shih, I., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100342q · Cited by 59

Detection of minimal residual disease

Dölken, G. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)82005-4 · Cited by 57

Rapid Electrokinetic Isolation of Cancer-Related Circulating Cell-Free DNA Directly from Blood

Sonnenberg, A., Marciniak, J. Y., Rassenti, L. Z., Ghia, E. M., Skowronski, E. A., Manouchehri, S., McCanna, J. P., Widhopf, G. F., Kipps, T. J., & Heller, M. J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.214874 · Cited by 57

Improving Indel Detection Specificity of the Ion Torrent PGM Benchtop Sequencer

Yeo, Z. X., Chan, M., Yap, Y. S., Ang, P., Rozen, S., & Lee, A. S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045798 · Cited by 56

Use of Magnetic Beads for Plasma Cell-free DNA Extraction: Toward Automation of Plasma DNA Analysis for Molecular Diagnostics

Stemmer, C., Beau‐Faller, M., Pencreach, E., et al. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.020750 · Cited by 55

Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer

Lefébure, B., Charbonnier, F., Fiore, F. D., Tuech, J., Pessot, F. L., Michot, F., Michel, P., & Frébourg, T. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c35c87 · Cited by 53

Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer

Takai, E., & Yachida, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i38.8480 · Cited by 53

Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer

Qian, X., Liu, J., Sun, Y., Wang, M., HuaiDing, L., Luo, G., Liu, X., Xiong, C., Liu, J., Liu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8684 · Cited by 52

Preferential Isolation of Fragmented DNA Enhances the Detection of Circulating Mutated k-ras DNA

Wang, M., Block, T. M., Steel, L., Brenner, D. E., & Su, Y. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026914 · Cited by 51

A surface-initiated enzymatic polymerization strategy for electrochemical DNA sensors

Wan, Y., Xu, H. F., Su, Y. L., Zhu, X., Song, S., & Fan, C. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.09.017 · Cited by 50

Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology

Kırkızlar, E., Zimmermann, B. G., Constantin, T. P., Swenerton, R., Hoang, B., Wayham, N. P., Babiarz, J., Demko, Z., Pelham, R. J., Kareht, S., et al. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.08.004 · Cited by 49

Implementing a strategy for on-chip detection of cell-free DNA fragments using GMR sensors: A translational application in cancer diagnostics using ALU elements

Dias, T., Cardoso, F. A., Martins, S. A. M., Martins, V. C., Cardoso, S., Gaspar, J., Monteiro, G. A., & Freitas, P. P. (2015) · Analytical Methods · doi:10.1039/c5ay01587a · Cited by 48

Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer

Chen, Z., Feng, J., Buzin, C. H., Liu, Q., Weiss, L. M., Kernstine, K. H., Somlo, G., & Sommer, S. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007220 · Cited by 47

Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients.

Chiang, P. W., Beer, D. G., Wei, W. L., Orringer, M. B., & Kurnit, D. M. (1999) · PubMed · Cited by 47

Ultrasensitive colorimetric detection of circulating tumor DNA using hybridization chain reaction and the pivot of triplex DNA

Li, R., Zou, L., Luo, Y., Zhang, M., & Ling, L. (2017) · Scientific Reports · doi:10.1038/srep44212 · Cited by 47

Extracellular tumor DNA in plasma and overall survival in breast cancer patients

Garcia, J. M., García‐Barberán, V., Silva, J., Peña, C., Domínguez, G., Sanchez, A., Sanfrutos, L., Provencio, M., Millán, I., Chaparro, D., et al. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20334 · Cited by 43

Tumor microenvironment complexity and therapeutic implications at a glance

Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784

Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy

Marrugo-Ramírez, J., Mir, M., & Samitier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102877 · Cited by 437

Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer

Sharma, M., Bakshi, A. K., Mittapelly, N., Gautam, S., Marwaha, D., Rai, N., Singh, N., Tiwari, P., Agarwal, N., Kumar, A., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.007 · Cited by 84